Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

FGFR3 single-chain antibody-protamine fusion protein and application thereof

A fusion protein and single-chain antibody technology, applied in the fields of genetic engineering and biopharmaceuticals, can solve problems such as the inability to fundamentally eradicate tumors, achieve development and in vivo safety assurance, increase protein expression, and facilitate separation and purification.

Inactive Publication Date: 2015-05-06
JILIN UNIV
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Although targeted inhibition of FGFR3-mediated signal transduction can inhibit tumor cell proliferation and tumor tissue growth, it still cannot fundamentally eradicate tumors, because FGF receptors are only a factor in tumor malignant growth, and other signal transduction pathways can still Activation promotes tumor cell proliferation and survival

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • FGFR3 single-chain antibody-protamine fusion protein and application thereof
  • FGFR3 single-chain antibody-protamine fusion protein and application thereof
  • FGFR3 single-chain antibody-protamine fusion protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] PCR synthesis of the R3‐P fusion gene.

[0045] According to the known FGFR3 monoclonal antibody sequence, we conducted bioinformatics analysis to find out its possible heavy chain and light chain sequences, and then compared and analyzed multiple reported FGFR3 ScFv sequences, according to the high consensus rate (>50%) codons, point mutations were carried out, and Cys (Gly was mutated to Cys) was introduced into the non-critical regions of the heavy chain and light chain at the same time, so as to facilitate the formation of disulfide bonds in the chain without affecting its binding function. At the same time to enhance the stability of the single chain antibody. The assembly sequence of each part is as follows figure 1 shown.

[0046] The nucleotide sequence and coding sequence of the entrusted company to synthesize the R3-fusion gene are shown in Table Seq ID No.2 and Seq ID No.1, respectively.

Embodiment 2

[0048] Construction of pET‐20b‐R3‐P expression vector.

[0049] In order to subclone the R3P gene into pET-20b, the ScFv-protamine (R3-P) sequence was synthesized by PCR using P1 and P2 as primers (see Table 1 for primer sequences).

[0050] PCR reaction system:

[0051]

[0052]

[0053] Reaction program: pre-denaturation at 98°C for 5min; denaturation at 98°C for 10min; annealing at 55°C for 15s; extension at 72°C for 1min, 30 cycles, and finally extension at 72°C for 5min. After no non-specific bands were detected by 1% agarose gel electrophoresis, the product DNA fragments were purified and recovered with a DNA gel recovery kit. The result is as figure 2 shown. Then the fragment was double-enzyme-digested with Nde Ⅰ and Xho Ⅰ, and carried out an enzyme ligation reaction with the pET-20b plasmid that was also double-digested with the two enzymes to obtain the pET-20b-R3-P plasmid.

[0054] Table 1 Primer Sequence

[0055] Primer Sequence (3'→5') ...

Embodiment 3

[0057] Obtaining of R3‐P fusion protein.

[0058] 1. Induced expression

[0059] The correctly sequenced pET‐20b‐R3‐P plasmid was transformed into Escherichia coli BL21 (DE3) competent cells, and positive transformants were screened on ampicillin resistance plates. A single colony of the screened positive recombinant bacteria BL21(DE3)pET‐20b‐R3‐P was inoculated into LB medium and cultured with shaking at 37°C for 16 hours. Then it was transferred to fresh LB medium at a ratio of 5%, and the expression conditions such as temperature, IPTG concentration and induction time were optimized respectively. The results showed that when the OD value was 0.6, induced by 1mM IPTG at 37°C for 3h, ultrasonic (200w, ultrasonic 5s, interval 5s, cycle 180 times) destroyed the bacteria, and the target protein expressed in the form of inclusion bodies could account for the total bacterial cells. More than 85% of the target protein, the results are as follows image 3 shown.

[0060] 2. Prot...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to FGFR3 single-chain antibody-protamine fusion protein and an application thereof. The protein is prepared by the following steps: adding the gene sequence of truncated encoded protamine to the 3' end of a gene for coding the FGFR3 single-chain antibody so as to obtain a fusion gene; cloning the fusion gene to a prokaryotic expression vector and inducing expression in escherichia coli cells; and separating and purifying an inclusion body. The fusion protein can be used as a nucleic acid carrying tool so as to carry small interfering RNA (such as siRNA) to attack various corresponding FGFR3 high-expression tumor cells (such as leukemia stem cell, bladder cancer cell, breast cancer cell and the like); by inducing the apoptosis, growth inhibition, differentiation and the like of tumor cells, finally the effects of inhibiting the growth, invasion and metastasis of tumors can be achieved.

Description

technical field [0001] The invention belongs to the fields of genetic engineering and biopharmaceuticals, and in particular relates to the preparation of a FGFR3 single-chain antibody-protamine fusion protein and its application in tumor cell-targeting drugs. Background technique [0002] Fibroblast growth factor (FGF) is a class of structurally related proteins encoded by members of the FGF gene family. At present, 23 members have been found, and their central regions all contain a segment with a homology of 30%-70%. amino acid sequence. The members of the large FGF family, as intercellular multifunctional signaling molecules, regulate various physiological functions of organisms. [0003] FGFs mainly exert regulatory functions through FGFR receptors on the cell membrane. FGFR belongs to tyrosine kinase receptors and is a single transmembrane protein, including the extracellular part, transmembrane part and intracellular tyrosine kinase structure combined with FGFs The do...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N15/62C12N15/70A61K47/42A61K31/7088A61P35/00
Inventor 肖业臣刘子轩张纪周李校堃
Owner JILIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com